The American Journal of Surgery
Volume 200, Issue 2 , Pages 197-203 , August 2010

Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio

  • Imran Bhatti, M.B.Ch.B., M.R.C.S.

      Affiliations

    • Division of Surgery, School of Graduate Entry Medicine and Health, University of Nottingham Medical School at, Derby, Derby City General Hospital, Derby DE22 3DT, UK
    • Corresponding Author InformationCorresponding author: Tel.: +44-33-272-4702; fax: +01-33-272-4697
    • ,
  • Oliver Peacock, B.Med.Sci.

      Affiliations

    • Department of Surgery, Derby City General Hospital, Derby, UK
    • ,
  • Gareth Lloyd, B.Med.Sci.

      Affiliations

    • Department of Surgery, Derby City General Hospital, Derby, UK
    • ,
  • Michael Larvin, M.D., F.R.C.S.

      Affiliations

    • Division of Surgery, School of Graduate Entry Medicine and Health, University of Nottingham Medical School at, Derby, Derby City General Hospital, Derby DE22 3DT, UK
    • ,
  • Richard I. Hall, M.D., F.R.C.S.

      Affiliations

    • Department of Surgery, Derby City General Hospital, Derby, UK

Received 3 June 2009 ,Revised 11 August 2009

References 

  1. James TA, Sheldon DG, Rajput A, et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004;101:2722–2726
  2. Alexakis N, Halloran C, Raraty M, et al. Current standards of surgery for pancreatic cancer. Br J Surg. 2004;91:1410–1427
  3. Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324–329
  4. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30
  5. Connor S, Bosonnet L, Ghaneh P, et al. Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg. 2004;91:1592–1599
  6. Sierzega M, Popiela T, Kulig J, et al. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas. 2006;33:240–245
  7. Berger AC, Watson JC, Ross EA, et al. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004;70:235–240
  8. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758–768
  9. Winter JM, Cameron JL, Campbell KA, et al. Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–1210
  10. Bassi C, Stocken DD, Olah A, et al. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg. 2005;22:353–363
  11. Ueda M, Endo I, Nakashima M, et al. Prognostic factors after resection of pancreatic cancer. World J Surg. 2009;33:104–110
  12. Kure S, Kaneko T, Takeda S, et al. Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford). 2005;7:129–134
  13. Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer. 2005;92:21–23
  14. Suzuki K, Aiura K, Kitagou M, et al. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology. 2004;51:847–853
  15. Yamaguchi K, Noshiro H, Shimizu S, et al. Long-term and short-term survivors after pancreatectomy for pancreatic cancer. Int Surg. 2000;85:71–76
  16. Fogar P, Sperti C, Basso D, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32:22–28
  17. Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–184
  18. Smith RA, Bosonnet L, Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–472
  19. Yamanaka T, Matsumoto S, Teramukai S, et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73:215–220
  20. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454:436–444
  21. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867
  22. McKay CJ, Glen P, McMillan DC. Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol. 2008;22:65–73
  23. Negrier S, Escudier B, Gomez F, et al. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol. 2002;13:1460–1468
  24. Donskov F, Hokland M, Marcussen N, et al. Monocytes and neutrophils as “bad guys” for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma—results from a randomised phase II trial. Br J Cancer. 2006;94:218–226
  25. Lord BI, Bronchud MH, Owens S, et al. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A. 1989;86:9499–9503
  26. Uchida T, Yamagiwa A. Kinetics of rG-CSF-induced neutrophilia in mice. Exp Hematol. 1992;20:152–155
  27. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 1996;88:335–340
  28. Aglietta M, Piacibello W, Sanavio F, et al. Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. J Clin Invest. 1989;83:551–557
  29. Ulich TR, del Castillo J, Watson LR, et al. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood. 1990;75:846–850
  30. Ulich TR, del Castillo J, Keys M, et al. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol. 1987;139:3406–3415
  31. Ulich TR, del Castillo J, Guo K, et al. The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation. Am J Pathol. 1989;134:149–159
  32. Ulich TR, del Castillo J, Guo KZ. In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood. 1989;73:108–110
  33. Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev. 2007;18:171–182
  34. Bellone G, Turletti A, Artusio E, et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol. 1999;155:537–547
  35. Bellone G, Smirne C, Mauri FA, et al. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol Immunother. 2006;55:684–698
  36. Romano F, Uggeri F, Crippa S, et al. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers. J Exp Clin Cancer Res. 2004;23:195–200
  37. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22:913–922
  38. Alexandrakis MG, Passam FH, Moschandrea IA, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003;26:135–140
  39. Petrie HT, Klassen LW, Kay HD. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol. 1985;134:230–234
  40. Shau HY, Kim A. Suppression of lymphokine-activated killer induction by neutrophils. J Immunol. 1988;141:4395–4402

PII: S0002-9610(09)00791-0

doi: 10.1016/j.amjsurg.2009.08.041

The American Journal of Surgery
Volume 200, Issue 2 , Pages 197-203 , August 2010

Article Tools

* Image Usage & Resolution